u/milan_wikstrom

Cosigning on paperwork. The boring documents are the ones that matter when a process starts.

Discharge from a specialist service at goal is a normal end point of that pathway. Whether prescribing continues in primary care afterwards is a local decision and is worth asking about at the start rather than at the end.

Supply notices from the regulator describe expected availability at a national level. They do not predict what any individual pharmacy has on the shelf next week.

That criterion is from the previous plan year. The current bulletin has different wording.

Questions about oral contraceptive absorption and gastric emptying are legitimate pharmacology questions with product-specific answers. A pharmacist can answer them properly; a board cannot.

Import rules are national and they distinguish between personal and commercial import, with different thresholds, documentation and consequences. A general answer is almost always wrong somewhere.

Careful — anything touching pregnancy is not a board question in any form.

Anything involving pregnancy, contraception efficacy or fertility planning belongs with a clinician. That is not a disclaimer, it is where the answers actually are.

appeal in writing even when they say a call is enough

the ICB decides the threshold and they are not the same across England

Pharmacy pricing on a private prescription is set by the pharmacy. The spread between them in a given month is routinely substantial, which is why a tracker built from member reports is more useful than any headline.

Have you asked the supplier what they declare?

In England, specialist weight management services are commissioned locally, so eligibility criteria and waiting times differ by ICB. There is no single national threshold to quote.

Have you asked for the clinical policy bulletin by number?

This is the whole method. Answer the criterion they named, not the decision in general.

Discharged at goal back to the GP, who would not continue it. Nobody had mentioned that this was how it ends.

That is a question for somebody qualified where you live, not for a ranked feed.

fatima_asante is right that regional stock is the structural answer rather than a trick.

Fertility changed faster than I expected with the weight loss. Nobody had raised it and I wish somebody had.

Correction: that is a formulary exclusion, not a prior authorisation denial. Different form, different route, different deadline.

Not convinced. That is a formulary exclusion rather than a prior authorisation denial, and the route to challenge it is different.

Two years and four months on a tier 3 list. Referral date and every letter kept, which turned out to matter when the service reorganised.

That criterion is from the previous plan year. The current bulletin has different wording.

A peer-to-peer conversation puts the prescribing clinician in front of a reviewing clinician. It bypasses the correspondence cycle entirely and is often the fastest available route.

Is this a discharge back to the GP, or a discontinuation?

Referral link removed and the post left up.

Disagreeing with this line: that is the arrangement in one nation and the question is about another.

Agreed that the vocabulary here is imprecise and it causes people to answer different questions to the ones asked.

Yes — four nations, four pathways, and threads that ignore that give people the wrong answer confidently.

Right, and keeping every date and reference number turns a frustrating process into an auditable one.

Same view. The second-level appeal is where mine turned, after a first-level denial that looked final.

Prior authorisation criteria are republished each plan year. A criterion that blocked you in one year may not exist in the next, so a denial is worth retesting after the turnover.

nothing on this board is a substitute for someone who knows your history

Disagreeing with this line: the absorption question has a product-specific answer and a pharmacist has it.

specialist service, not GP, for tier 3 in most of England

Clearance took four days and the carrier took eleven. I had been blaming entirely the wrong stage for a year.

Appeal deadlines run from the date on the determination letter. They are strict, they are short, and a missed deadline usually forfeits that level entirely.

The scheme cap in Ireland was the single most useful thing I learned in a year of reading this board.

the answer for New Zealand does not apply anywhere else

declared value and description are the shipper’s decisions, ask what they use

Missed a deadline because I counted from when I opened the envelope.

vikram_mbeki is right that this is documentation rather than persuasion. It took me a year to accept that.

an online consultation that asks you nothing is not a consultation

no referral links, ever, and that rule is why the pricing threads work

the answer for Spain does not apply anywhere else